About Checkmate Therapeutics
Checkmate Therapeutics is a company based in Seoul (South Korea) founded in 2019. It operates as a B2B. Checkmate Therapeutics operates in a competitive market with competitors including Intima Bioscience, Draconis Pharma, Ilico Genetics, Shgsmed.com and TLR Therapeutics, among others.
- Headquarter Seoul, South Korea
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Checkmate Therapeutics
Detailed funding history for Checkmate Therapeutics
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Checkmate Therapeutics
Investment portfolio details for Checkmate Therapeutics
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Checkmate Therapeutics
Detailed financials for Checkmate Therapeutics
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Checkmate Therapeutics Comparisons
Peer comparison for Checkmate Therapeutics
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Checkmate Therapeutics
Checkmate Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Intima Bioscience, Draconis Pharma, Ilico Genetics, Shgsmed.com and TLR Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Therapeutics for gastrointestinal cancer are developed using CRISPR gene-editing.
|
|
| Locked | Locked | Locked |
Therapeutic solutions for cancer, pain, and immune diseases are developed.
|
|
| Locked | Locked | Locked |
Developer of diagostic test for detection of gastric cancer
|
|
| Locked | Locked | Locked |
Drugs for esophageal cancer treatment are developed using photodynamic therapy.
|
|
| Locked | Locked | Locked |
Develops innovative therapeutics for treating myelodysplastic syndrome and gastric cancer.
|
Detailed competitors of Checkmate Therapeutics
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Checkmate Therapeutics
Complete news archive for Checkmate Therapeutics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Checkmate Therapeutics
Checkmate Therapeutics was founded in 2019.
Checkmate Therapeutics is headquartered in Seoul, South Korea.
Checkmate Therapeutics operates with a B2B model, focusing on providing healthcare solutions, advancing biotech innovations, therapeutics, and oncology and neurology. Develops innovative therapeutic technologies for cancer and neurological disorders. It emphasizes efficiency, client-focused solutions, and growth, fostering partnerships and innovation in its operations.
Checkmate Therapeutics's top competitors include Draconis Pharma, Ilico Genetics and Intima Bioscience.